UPXI - UPEXI, INC.


1.08
0.295   27.306%

Share volume: 22,191,423
Last Updated: 03-04-2026
Pharmaceutical Products/Medicinal Chemicals: 2.32%

PREVIOUS CLOSE
CHG
CHG%

$0.79
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
48%
Profitability 35%
Dept financing 43%
Liquidity 21%
Performance 70%
Company vs Stock growth
vs
Performance
5 Days
22.73%
1 Month
-0.92%
3 Months
-59.40%
6 Months
-82.12%
1 Year
-56.63%
2 Year
97.08%
Key data
Stock price
$1.08
P/E Ratio 
0.00
DAY RANGE
$0.88 - $1.17
EPS 
-$5.66
52 WEEK RANGE
$0.54 - $22.57
52 WEEK CHANGE
-$60.58
MARKET CAP 
100.663 M
YIELD 
N/A
SHARES OUTSTANDING 
69.761 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
1.15
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$8,552,948
AVERAGE 30 VOLUME 
$6,298,639
Company detail
CEO: Allan Marshall
Region: US
Website: www.upexi.com
Employees: 59
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand name. The company sells its products through direct-to-consumer network, wholesale partnerships, and third-party platform. It also focuses on cryptocurrency industry and management of cash assets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Tampa, Florida.

Recent news